These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16493961)

  • 1. [Stomach diseases].
    Nichita C; Viani F; Vouillamoz F; Jornod P; Kessler-Brondolo V; Dorta G
    Rev Med Suisse; 2006 Jan; 2(49):182-6, 188-90. PubMed ID: 16493961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peptic diseases].
    Vouillamoz D; Viani F; Jornod P; Kessler V; Ehmann T; Dorta G
    Rev Med Suisse; 2005 Jan; 1(3):200-2, 205-8. PubMed ID: 15770814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
    Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
    Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines in the medical treatment of Helicobacter pylori infection.
    Dzieniszewski J; Jarosz M
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():143-54. PubMed ID: 17033112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The many manifestations of gastroesophageal reflux disease: presentation, evaluation, and treatment.
    Richter JE
    Gastroenterol Clin North Am; 2007 Sep; 36(3):577-99, viii-ix. PubMed ID: 17950439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A; Scheiman J
    Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
    Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
    Montalban C; Norman F
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations].
    Berrutti M; Fagoonee S; Astegiano M; Pellicano R; Rizzetto M
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):153-6. PubMed ID: 17557043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and benign upper digestive disease.
    Lai LH; Sung JJ
    Best Pract Res Clin Gastroenterol; 2007; 21(2):261-79. PubMed ID: 17382276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.
    Caselli M; Zullo A; Maconi G; Parente F; Alvisi V; Casetti T; Sorrentino D; Gasbarrini G;
    Dig Liver Dis; 2007 Aug; 39(8):782-9. PubMed ID: 17606419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication for the prevention of gastric cancer.
    Kuipers EJ; Sipponen P
    Helicobacter; 2006 Oct; 11 Suppl 1():52-7. PubMed ID: 16925613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.